Physician profile
Saira Bana
NPI 1912484924
$1,064.99
in general payments reported to CMS, 2019-2025
21 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $224 · 2023: $688 · 2024: $27.56 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $841.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $149.56 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $148.67 | 2022 | |
| Horizon Therapeutics Plc | $124.04 | 2023 | Uplizna |
| Ultragenyx Pharmaceutical INC. | $75.00 | 2022 | |
| Pfizer INC. | $73.83 | 2023 | |
| Sumitomo Pharma America, INC. | $62.48 | 2023 | Gemtesa |
| Glaxosmithkline, LLC. | $58.41 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Inspire Medical Systems, INC. | $52.41 | 2024-2025 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $37.28 | 2023-2025 | Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $36.89 | 2023 | |
| Lundbeck LLC | $34.76 | 2023 | Rexulti |
| Xeris Pharmaceuticals, INC. | $32.63 | 2023 | Gvoke Hypopen |
| Exact Sciences Corporation | $26.91 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $24.99 | 2023 | |
| Dexcom, INC. | $22.97 | 2025 | Dexcom G6 Transmitter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $20.17 | 2023 | Verquvo, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.28 | 2025 | Jardiance |
| Hikma Pharmaceuticals USA | $17.12 | 2023 | Ryaltris |
| Novartis Pharmaceuticals Corporation | $16.78 | 2023 | |
| Azurity Pharmaceuticals, INC. | $16.64 | 2023 | Edarbi |
| Otsuka America Pharmaceutical, INC. | $16.17 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saira Bana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.